Gerald Cochran, MSW, PhD

Research Interests

  • Health Care and Health Services
  • Behavioral Health
  • Substance Abuse
  • Program Evaluation
  • Evidence-Based Practice
  • Latent Variable Modeling

Languages

  • English
  • Spanish

Academic Information

  • Departments: Internal Medicine - Associate Professor, Psychiatry - Adjunct Associate Professor
  • Divisions: Adult Psychiatry, Epidemiology

Academic Office Information

  • 801-213-0654
  • Colorow Building
    Epidemiology
    383 Colorow Drive, Room: 203G
    Salt Lake City, UT 84108

Research Statement

Dr. Cochran earned his Ph.D. from The University of Texas at Austin School of Social Work and completed postdoctoral training with the Johns Hopkins School of Medicine, Department of Psychiatry and Behavioral Sciences. Dr. Cochran’s research interests are centered on behavioral health services research. His area of expertise involves identifying and studying appropriate care for underserved populations in healthcare settings, with particular emphasis on individuals who misuse drugs and alcohol. Dr. Cochran’s work aims to improve substance abuse prevention and treatment services provided in health care settings.

Education History

Type School Degree
Research Fellow Johns Hopkins University School of Medicine
Behavioral Pharmacology of Substance Abuse
Postdoctoral Research Fellow
Doctoral Training The University of Texas at Austin
Social Work
Ph.D.
Graduate Training University of Utah
M.S.W.
Undergraduate Brigham Young University
Major: Social Work; Minor: Spanish
B.S.

Selected Publications

Journal Article

  1. Cochran G, Chen Q, Field C, Seybert A, Hruschak V, Jaber A, Gordon AJ, Tarter R (In Press). A community pharmacy-led intervention for opioid medication misuse: A small-scale randomized clinical trial. Drug Alcohol Depend.
  2. Lobo C, Cochran G, Chang J, Gellad W, Gordon AJ, Jalal H, Ciganic J, Kelley D, Donohue JM (In Press). Associations between the specialty of opioid prescribers and opioid addiction, misuse and overdose outcomes. Pain Med.
  3. Cochran G, Pacella M, Ringwald W, Repine M, Hruschak V, Beaugard C, Sewall C, Rosen D, Alarcon LH, Tarkin IS, Moloney GB, Corcos A (In Press). Opioid use patterns and risk characteristics among injured patients. Subst Abus.
  4. Hruschak V, Cochran G, Wasan A (In Press). Psychosocial interventions for chronic pain and comorbid opioid misuse: a narrative review of the literature. J Opioid Manag.
  5. Hruschak, V Hildenbrand, A amp Cochran, G (In Press). Psychiatric Comorbidity and Co-occurring Opioid Misuse: Depression Mediates the Relationship between Post-Traumatic Stress Disorder and Opioid Misuse in Community Pharmacy Settings. Subst Abus.
  6. Rosen D, Engel R, Beaugard C, Davis N, Cochran G (In Press). Baby boomer’s substance abuse and researcher indifference. J Gerontol Soc Wk.
  7. Lindley B, Cox N, Cochran G (In press). Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: A review. Integrated Pharmacy Research and Practice.
  8. Moyo P, Gellad W, Sabik L, Cochran G, Cole E, Kelley D, Donohue J (In press). Opioid Prescribing Safety Measures in Medicaid Enrollees with and without Cancer. Am J Prev Med.
  9. Bhardwaj SB, Cochran G, Kmiec J (2019). Opioid Overdose History and Awareness of Naloxone in Patients Seeking Outpatient Detoxification. J Opioid Manag, 15(3), 253.
  10. Cole E, DiDomenico E, Cochran G, Gordon A, Gellad W, Pringle J, Warwick J, Chang C-C, Kmiec J, Kelley D, Donohue J (2019). The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder. J Gen Intern Med, 34(6), 936-943.
  11. Cole ES, DiDomenico E, Cochran G, Gordon AJ, Gellad WF, Pringle J, Warwick J, Chang CH, Kim JY, Kmiec J, Kelley D, Donohue JM (2019). The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder. J Gen Intern Med, 34(6), 936-943.
  12. Bhardwaj SB, Cochran G, Kmiec J (2019). Opioid overdose history and awareness of naloxone in patients seeking outpatient detoxification. J Opioid Manag, 15(3), 253-259.
  13. Lo-Ciganic W, Huang JL, Zhang HH, Weiss JC, Wu Y, Kwoh CK, Donohue JM, Cochran G, Gordon AJ, Malone DC, Kuza CC, Gellad WF (2019). Use of Machine Learning to Predict Risk of Opioid Overdose among Medicare Beneficiaries Prescribed Opioids. JAMA Netw Open, 2(3), e190968.
  14. Lo-Ciganic WH, Huang JL, Zhang HH, Weiss JC, Wu Y, Kwoh CK, Donohue JM, Cochran G, Gordon AJ, Malone DC, Kuza CC, Gellad WF (2019). Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions. JAMA Netw Open, 2(3), e190968.
  15. Rosen D, Engel RJ, Beaugard C, Davis N, Cochran G (2018). Baby Boomer's Substance Abuse and Researcher Indifference. J Gerontol Soc Wk, 62(1), 16-28.
  16. Theisen KM, Myrga JM, Hale N, Cochran G, Sewall C, Macleod LC, Jacobs BL, Davies BJ (2018). Excessive Opioid Prescribing After Major Urologic Procedures. Urology, 123, 101-107.
  17. Hruschak V, Cochran G (2018). Psychosocial predictors in the transition from acute to chronic pain: a systematic review. Psychol Health Med, 23(10), 1151-1167.
  18. Cochran G, Lo-Ciganic W-H, Gellad W, Gordon AJ, Cole E, Lobo C, Frazier W, Zheng P, Kelley D, Donohue J (2018). Prescription Opioid Quality Measures Applied among Pennsylvania Medicaid Enrollees. J Manag Care Spec Pharm, 24(9), 875-885.
  19. Hruschak V, Cochran G, Wasan AD (2018). Psychosocial interventions for chronic pain and comorbid prescription opioid use disorders: A narrative review of the literature. J Opioid Manag, 14(5), 345-358.
  20. Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Cole E, Lobo C, Frazier W, Zheng P, Chang CH, Kelley D, Donohue JM (2019). Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees. J Manag Care Spec Pharm, 24(9), 875-885.
  21. Tarter RE, Cochran G, Reynolds M (2018). Prevention of Opioid Addiction. Commonwealth: A Journal of Pennsylvania Politics and Policy, 20(1), 38-60.
  22. Cochran G, Field CA, Karp J, Seybert AL, Chen Q, Ringwald W, Hruschak V, Chickering S, Kincman J, Jaber A, Tarter R (2018). A community pharmacy intervention for opioid medication misuse: A pilot randomized clinical trial. J Am Pharm Assoc (2003), 58(4), 395-403.
  23. Ylioja T, Vivek R, Ambrosino R, Davis E, Douaihy A, Slovenkay K, Kogut V, Frenak B, Palombo K, Schulze A, Cochran G, Tindle H (2017). Using Bioinformatics to Treat Hospitalized Smokers: Successes and Challenges of a Tobacco Treatment Service. Jt Comm J Qual Patient Saf, 43(12), 621-632.
  24. Ylioja T, Cochran G, Woodford MR, Renn KA (2018). Frequent Experience of LGBQ Microaggression on Campus Associated With Smoking Among Sexual Minority College Students. Nicotine Tob Res, 20(3), 340-346.
  25. Cochran G, Field C, Karp J, Seybert AL, Chen Q, Ringwald W, Hruschak V, Chickering S, Kincman J, Jaber A, Tarter R (2017). A community pharmacy intervention for opioid medication misuse: A pilot randomized clinical trial. J Am Pharm Assoc (Wash DC), 58(4), 395-403.
  26. Cochran GT, Hruschak V, Abdullah W, Krans E, Douaihy AB, Bobby S, Fusco R, Tarter R (2018). Optimizing Pregnancy Treatment Interventions for Moms (OPTI-Mom): A Pilot Study. J Addict Med, 12(1), 72-79.
  27. Ylioja T, Reddy V, Ambrosino R, Davis EM, Douaihy A, Slovenkay K, Kogut V, Frenak B, Palombo K, Schulze A, Cochran G, Tindle HA (2017). Using Bioinformatics to Treat Hospitalized Smokers: Successes and Challenges of a Tobacco Treatment Service. Jt Comm J Qual Patient Saf, 43(12), 621-632.
  28. Cochran G, Hruschak V, Bacci JL, Hohmeier KC, Tarter R (2017). Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis. Res Social Adm Pharm, 13(6), 1055-1061.
  29. Suffoletto B, Yanta J, Kurtz R, Cochran G, Douaihy A, Chung T (2017). Acceptability of an Opioid Relapse Prevention Text-message Intervention for Emergency Department Patients. J Addict Med, 11(6), 475-482.
  30. Cochran GT, Engel RJ, Hruschak VJ, Tarter RE (2017). Prescription Opioid Misuse Among Rural Community Pharmacy Patients: Pilot Study for Screening and Implications for Future Practice and Research. J Pharm Pract, 30(5), 498-505.
  31. Cochran G, McCarthy R, Gordon AJ, Tarter RE (2017). Opioid medication misuse among unhealthy drinkers. Drug Alcohol Depend, 179, 13-17.
  32. Ylioja T, Cochran G, Chang Y, Tindle HA, Rigotti NA (2017). Postdischarge smoking cessation in subgroups of hospitalized smokers: A latent class analysis. Subst Abus, 38(4), 493-497.
  33. Frazier W, Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Chang CH, Donohue JM (2017). Medication-Assisted Treatment and Opioid Use Before and After Overdose in Pennsylvania Medicaid. JAMA, 318(8), 750-752.
  34. Hruschak V Msw Rsw, Cochran G (2017). Psychosocial and environmental factors in the prognosis of individuals with chronic pain and comorbid mental health. Soc Work Health Care, 56(7), 573-587.
  35. Cochran G, Rosen D, McCarthy RM, Engel RJ (2017). Risk Factors for Symptoms of Prescription Opioid Misuse: Do Older Adults Differ from Younger Adult Patients? J Gerontol Soc Wk, 60(6-7), 443-457.
  36. Bahorik AL, Greeno CG, Cochran G, Cornelius JR, Eack SM (2017). Motivation deficits and use of alcohol and illicit drugs among individuals with schizophrenia. Psychiatry Res, 253, 391-397.
  37. Cochran G, Gordon AJ, Gellad WF, Chang CH, Lo-Ciganic WH, Lobo C, Cole E, Frazier W, Zheng P, Kelley D, Donohue JM (2017). Medicaid prior authorization and opioid medication abuse and overdose. Am J Manag Care, 23(5), e164-e171.
  38. Cochran G, Gordon AJ, Lo-Ciganic WH, Gellad WF, Frazier W, Lobo C, Chang CH, Zheng P, Donohue JM (2017). An Examination of Claims-based Predictors of Overdose from a Large Medicaid Program. Med Care, 55(3), 291-298.
  39. Cochran G, Hruschak V, DeFosse B, Hohmeier KC (2016). Prescription opioid abuse: pharmacists' perspective and response. Integr Pharm Res Pract, 5, 65-73.
  40. Cochran GL, Barrett RS, Horn SD (2016). Comparison of medication safety systems in critical access hospitals: Combined analysis of two studies. Am J Health Syst Pharm, 73(15), 1167-73.
  41. Cochran G, Field C, Foreman M, Ylioja T, Brown CV (2016). Effects of brief intervention on subgroups of injured patients who drink at risk levels. Inj Prev, 22(3), 221-5.
  42. Knowlton AR, Weir B, Fields J, Cochran G, McWilliams J, Wissow L, Lawner BJ (2016). Pediatric Use of Emergency Medical Services: The Role of Chronic Illnesses and Behavioral Health Problems. Prehosp Emerg Care, 20(3), 362-8.
  43. Cochran G, Bacci JL, Ylioja T, Hruschak V, Miller S, Seybert AL, Tarter R (2016). Prescription opioid use: Patient characteristics and misuse in community pharmacy. J Am Pharm Assoc (2003), 56(3), 248-256.e6.
  44. Lo-Ciganic WH, Gellad WF, Gordon AJ, Cochran G, Zemaitis MA, Cathers T, Kelley D, Donohue JM (2016). Association between trajectories of buprenorphine treatment and emergency department and in-patient utilization. Addiction, 111(5), 892-902.
  45. Cochran G, Gordon AJ, Field C, Bacci J, Dhital R, Ylioja T, Stitzer M, Kelly T, Tarter R (2016). Developing a framework of care for opioid medication misuse in community pharmacy. Res Social Adm Pharm, 12(2), 293-301.
  46. Cochran G, Field C, DiClemente C, Caetano R (2016). Latent Classes Among Recipients of a Brief Alcohol Intervention: A Replication Analysis. Behav Med, 42(1), 29-38.
  47. Gordon AJ, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Kelley D, Donohue JM (2015). Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid Program. J Addict Med, 9(6), 470-7.
  48. Cochran G, Rubinstein J, Bacci JL, Ylioja T, Tarter R (2015). Screening Community Pharmacy Patients for Risk of Prescription Opioid Misuse. J Addict Med, 9(5), 411-6.
  49. Cochran G, Field C, Lawson K (2015). Pharmacists Who Screen and Discuss Opioid Misuse With Patients: Future Directions for Research and Practice. J Pharm Pract, 28(4), 404-12.
  50. Cochran G, Field C, Caetano R (2015). Changes in Classes of Injury-Related Risks and Consequences of Risk-Level Drinking: a Latent Transition Analysis. J Behav Health Serv Res, 42(3), 355-66.
  51. Cochran G, Stitzer M, Campbell AN, Hu MC, Vandrey R, Nunes EV (2015). Web-based treatment for substance use disorders: differential effects by primary substance. Addict Behav, 45, 191-4.
  52. Krans EE, Cochran G, Bogen DL (2015). Caring for Opioid-dependent Pregnant Women: Prenatal and Postpartum Care Considerations. Clin Obstet Gynecol, 58(2), 370-9.
  53. Cochran G, Woo B, Lo-Ciganic WH, Gordon AJ, Donohue JM, Gellad WF (2015). Defining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review. Subst Abus, 36(2), 192-202.
  54. Cochran G, Stitzer M, Nunes EV, Hu MC, Campbell A (2014). Clinically relevant characteristics associated with early treatment drug use versus abstinence. Addict Sci Clin Pract, 9, 6.
  55. Field CA, Cochran G, Caetano R, Foreman M, Brown CV (2014). Postdischarge nonmedical use of prescription opioids in at-risk drinkers admitted to urban level I trauma centers. J Trauma Acute Care Surg, 76(3), 833-9.
  56. Cochran G, Roll J, Jackson R, Kennedy J (2014). Health care reform and the behavioral health workforce. J Soc Work Pract Addict, 14(2), 127-40.
  57. Cochran G, Field C, Caetano R (2014). Injury-related consequences of alcohol misuse among injured patients who received screening and brief intervention for alcohol: a latent class analysis. Subst Abus, 35(2), 153-62.
  58. Field CA, Cochran G, Caetano R (2013). Treatment utilization and unmet treatment need among Hispanics following brief intervention. Alcohol Clin Exp Res, 37(2), 300-7.
  59. Cochran G, Field C, Lawson K, Erickson C (2013). Pharmacists' Knowledge, Attitudes, and Beliefs Regarding Screening and Brief Intervention for Prescription Opioid Abuse: A Survey of Utah and Texas Pharmacists. J Pharm Health Serv Res, 4, 71-9.
  60. Field CA, Cochran G, Caetano R (2012). Ethnic differences in the effect of drug use and drug dependence on brief motivational interventions targeting alcohol use. Drug Alcohol Depend, 126(1-2), 21-6.
  61. Thompson SJ, Cochran G, Barczyk AN (2012). Family functioning and mental health in runaway youth: association with posttraumatic stress symptoms. J Trauma Stress, 25(5), 598-601.
  62. Parrish DE, von Sternberg K, Velasquez MM, Cochran G, Sampson M, Mullen PD (2012). Characteristics and factors associated with the risk of a nicotine exposed pregnancy: expanding the CHOICES preconception counseling model to tobacco. Matern Child Health J, 16(6), 1224-31.
  63. Cochran G, Montgomery KL, Bell H (2012). Translating evidence-based practices into policy: a case study in Texas. Soc Work Health Care, 51(5), 383-401.
  64. Cochran G, Davis K (2012). Social work and the Uniform Accident and Sickness Policy Provision Law: a pilot project. Soc Work, 57(1), 39-48.
  65. Field CA, Cochran G, Foulkrod K, Brown C (2011). Trauma healthcare providers' knowledge of alcohol abuse. J Trauma, 70(6), 1437-43.
  66. Cochran G (2010). Analysis of the Uniform Accident And Sickness Policy Provision Law: lessons for social work practice, policy, and research. Soc Work Health Care, 49(7), 647-68.
  67. Cochran G, Landuyt N (2010). A survey of continuing education programs conducted by Professional Development: The International Journal of Continuing Social Work Education. Professional Development: The International Journal of Continuing Social Work, 13(2), 55-72.
  68. Cochran G (2010). Social policy advocacy evaluation: A more complete model for social work. Professional Development: The International Journal of Continuing Social Work, 13(1), 27-39.
  69. Cochran G, Montgomery K, Rubin A (2010). Does evidence-based practice influence state legislators’ decision-making process? An exploratory study. J Policy Pract, 9(3), 263-83.
  70. Roby J, Cochran G (2007). Child headed households in Mozambique: Towards needs-based policy and practice. Soc Dev Issues, 29(3), 19-32.
  71. Cochran G (2005). Investigation of child headed households in Mozambique, Africa. Brigham Young University Journal of Undergraduate Research.
  72. Myrga J, Hale N, Cochran G, Sewall C, Jacobs B, Davies B (In Press). Excessive Opioid Prescribing After Major Urologic Procedures. Urology.

Review

  1. Cochran G, Field C (2013). Brief intervention and social work: a primer for practice and policy. [Review]. Soc Work Public Health, 28(3-4), 248-63.

Book Chapter

  1. Cochran G, Ylioja T (2016). Drug Use and Minority Health in the US: Prevalence, Causes, and Future Directions. In Copeland V (Ed.), Contemporary Issues for People of Color: Surviving and Thriving in the US Today. Santa Barbara, CA: ABC-CLIO.
  2. Cochran G, Thompson SJ (2012). Alcohol Abuse Prevention and Treatment in Health Care Settings: Screening and Brief Intervention. In Maars J (Ed.), Alcohol Dependence and Addiction (pp. 55-78). Hauppauge, NY: Nova Science Publishers.
  3. Gordon AJ, Cochran G, Smid MC, Manhapra A, Kertesz SG (In Press). Prescribing, prescription monitoring, and health policy. In Kelly JF, Wakeman S (Eds.), Treating Opioid Addiction. Willowick, Ohio: Springer International.

Book Review

  1. Cochran G (2011). Book Review. [Review of the book The Practice of Research in Social Work]. Research on Social Work Practice, 21, 121-4.

Letter

  1. Gordon A, Lo-Ciganic WH, Cochran G, Gellad WF, Cathers T, Donohue JM (2016). Treatment Quality for Buprenorphine Care: The Pot at the End of the Rainbow. [Letter to the editor]. J Addict Med, 10(3), 210-1.
  2. Aruri M, Cochran G, Pringle J (In Press). Role of pharmacists in the opioid use disorder (OUD) crisis [Letter to the editor]. Res Social Adm Pharm.

Abstract

  1. Cochran, G Lo-Ciganic, W-H, Gellad, W, Gordon, AJ, Cole, E, Lobo, C, Frazier, W, Zheng, P, Kelley, D, amp Donohue, JM (In press). Quality Measures of Prescription Opioid Utilization in a Large State Medicaid Program. [Abstract]. Substance Abuse.
  2. Sakai, H, Hruschak, V, Cochran, G, amp Copeland, V (In press). Virtual Reality-Based Training for Screening, Brief Intervention, and Referral to Treatment in Social Work Education [Abstract]. Substance Abuse.
  3. Cochran G, Rubinstein J, Bacci J, Ylioja T, Tarter R (2016). Community pharmacy and opioid pain medication: Screening patients who misuse or are at risk for misuse; also presented orally at the Association for Medical Education and Research in Substance Abuse 39th National Conference, Washington, DC [Abstract]. Substance Abuse, 37(2), 46A.
  4. Cochran G, Gordon A, Field C, Bacci J, Dhital R, Ylioja T, Stitzer M, Kelly T, Tarter R (2016). A continuum of care model for opioid misuse in community pharmacy; also presented orally at the Association for Medical Education and Research in Substance Abuse 39th National Conference, Washington, DC [Abstract]. Substance Abuse, 37(2), 47A.
  5. Cochran G, Woo B, Lo-Ciganic WH, Gordon A, Donohue J, Wei-Hsuan L, Gellad W (2015). Defining non-medical use of prescription opioids within health care claims: A systematic review; also presented orally at the Association for Medical Education and Research in Substance Abuse 38th National Conference, San Francisco, CA [Abstract]. Substance Abuse, 36(2), 67A.
  6. Cochran G, Brodie B, Bell A, Bennett A (2015). Factors associated with opioid overdose resuscitation; also presented orally at the Association for Medical Education and Research in Substance Abuse 38th National Conference, San Francisco, CA [Abstract]. Substance Abuse, 36(2), 48A.
  7. Cochran G, Field C, Foreman M, Brown C (2015). Effects of brief Intervention on subclasses of injured patients who rink at risk levels; also presented orally at the Association for Medical Education and Research in Substance Abuse 38th National Conference, San Francisco, CA [Abstract]. Substance Abuse, 36(2), 75A.
  8. Field C, Cochran G, Caetano R (2012). The role of drug use in brief alcohol interventions: A multi-ethnic/racial analysis [Abstract]. Addiction Science and Clinical Practice, 7(Suppl 1), A18.
  9. Cochran GT (2011). Latent predictors of change from screening and brief alcohol interventions: A mixture modeling approach; also presented orally at the Texas Research Society on Alcoholism Annual Scientific Meeting, Lubbock, TX [Abstract]. Alcoholism—Clinical and Experimental Research, 35(6), 337A-337A.
  10. Parrish DE, von Sternberg K, Cochran G, Sampson M, Mullen P, Velasquez MM (2009). Alcohol and nicotine exposed pregnancies: Common and unique characteristics associated with risk [Abstract]. Alcoholism—Clinical and Experimental Research, 33(6), 344A-344A.

Other

  1. Cochran G (July/August 2010). The Promise and Pitfalls of Organizational Change. Nonprofit World (28(4), pp. 7-11).

Report

  1. DiDomenico E, Kelley D, Cole E, Pringle J, Warwick J, Donohue J, Gellad W, Cochran G, Kmic J, Bear T, Chang J, Kim JY, Gordon A (2018). Project Rural Access to MAT in Pennsylvania (RAMP): Mid-Grant Report. Pittsburgh, PA: Medicaid Research Center, University of Pittsburgh..
  2. Rosen D, Brusoski M, Engel R, Cochran G (2018). The Integrated Health Care Training Corps: Corps: A collaboration between the University of Pittsburgh School of Social Work and the UPMC Health Plan: Year 3 Report. Pittsburgh: University of Pittsburgh.
  3. Donohue J, Cole E, Kim JY, Zheng P, Lo-Ciganic W-H, Gordon A, Gellad A, Cochran G (2017). Report on Opioid Prescribing Quality Measures, Opioid Use, Opioid Use Disorder, and Medication-Assisted Treatment in Pennsylvania Medicaid: 2013-2015. Medicaid Research Center, University of Pittsburgh.
  4. Cochran G, Ylioja T, Fisher S (2015). Treatment Guide: Targeted medication therapy management for prescription opioid misuse. Pittsburgh, PA: University of Pittsburgh School of Social Work.
  5. Donohue J, Cochran G, Gordon A, Zemaitis M, Gellad W (2013). Report on Opioid Use Disorder and Buprenorphine Use in Pennsylvania Medicaid. Center for Pharmaceutical Policy and Prescribing.
  6. Cochran G (2010). The Use of the SEE Data in Texas: The Case of the University of Texas at San Antonio. Austin, TX: Center for Social Work Research, Institute for Organizational Excellence.
  7. Cochran G, Landuyt N (2010). The Second Annual Survey of Continuing Education Programs Conducted by Professional Development: The International Journal of Continuing Social Work Education. Austin, TX: Center for Social Work Research, Institute for Organizational Excellence.
  8. Cochran G (2010). The Use of the SEE Data in Texas: The Case of the Texas Parks and Wildlife Department. Austin, TX: Center for Social Work Research, Institute for Organizational Excellence.
  9. Fong R, Urban B, Cochran G (2008). Evaluation of south Texas coalition against human trafficking (STCAHT). Austin, TX: Center for Social Work Research.
  10. Fong R, Urban B, Cochran G (2008). Evaluation of Catholic Charities of San Antonio’s human trafficking trainings and presentations. Austin, TX: Center for Social Work Research.
  11. Cochran G (2008). CHIP: A Utah success story. Salt Lake City, UT: Voices for Utah Children.
  12. McRoy R, Ayers-Lopez S, Wallace M, Fong R, Schwartz A, Leonardo A, Simons O, Popham A, Wheeler K, Boyd K, Edwards E, Tostada B, Holmes T, Cochran G, Kim S, Steinley-Bungarner M, Naik R, Cody P, Barczyk A, Burt B (2008). Adoptive and foster couples retreat and support network program report: Part two. Austin, TX: Center for Social Work Research.
  13. McRoy R, Ayers-Lopez S, Wallace M, Fong R, Schwartz A, Leonardo A, Simons O, Popham A, Wheeler K, Boyd K, Edwards E, Tostada B, Holmes T, Cochran G, Kim S, Steinley-Bungarner M, Naik R, Cody P, Barczyk A, Burt B (2008). Adoptive and foster couples retreat and support network program report 2007-2008. Austin, TX: Center for Social Work Research.
  14. Harris N, Frost CJ, Lundahl B, Yaffe J, Cochran G, Moran M, Smith R (2005). Salt Lake City Weed and Seed: Final report. Salt Lake City, UT: Social Research Institute, University of Utah.

Video/Film/CD/Web/Podcast

  1. Cochran G (2018). Improving Opioid Addiction Treatment for Pregnant Women [Podcast]. Journal of Addiction Medicine. Available: https://journals.lww.com/journaladdictionmedicine/pages/podcastepisodes.aspx?podcastid=1.